Genetic Factors in Parkinson’s Disease

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

Genetic Factors in Parkinson’s Disease.

Genetic factors play a significant role in the development of Parkinson’s disease (PD), though the interaction between genes and environmental factors is complex. While most cases of PD are considered sporadic and not inherited, about 10-15% of cases are linked to genetic mutations. Below are the key genetic factors involved in Parkinson’s disease:

1. Monogenic Forms of Parkinson’s Disease:

Some rare cases of PD are caused by single-gene mutations, leading to what is called “monogenic” PD. These forms of PD often have an earlier onset (before the age of 50) and a clear family history.

Key Genes Involved:

SNCA (α-synuclein):
- One of the most important genes linked to PD. Mutations or duplications of this gene can cause the accumulation of the protein α-synuclein in the brain, forming Lewy bodies, a hallmark of Parkinson’s disease.
- This gene was the first discovered to be linked to familial PD, and mutations here are rare but significant.
LRRK2 (Leucine-rich repeat kinase 2):
- LRRK2 mutations are the most common genetic cause of both familial and sporadic Parkinson’s disease, especially in certain ethnic groups, such as Ashkenazi Jews and North African Arabs.
- The LRRK2 gene is involved in several cellular processes, and mutations can lead to neuronal dysfunction.
PARK7 (DJ-1):
- Mutations in the DJ-1 gene are linked to early-onset PD. This gene is involved in protecting cells from oxidative stress.
PINK1 (PTEN-induced kinase 1):
- PINK1 mutations are another cause of early-onset PD. The PINK1 gene helps protect mitochondria, the energy-producing organelles in cells, from stress. Dysfunction of this gene leads to mitochondrial impairment, which contributes to neuronal death.
PRKN (Parkin):
- Mutations in the Parkin gene are the most common cause of early-onset PD. Parkin plays a key role in helping cells eliminate damaged proteins, and dysfunction in this process can lead to PD.
VPS35 (Vacuolar protein sorting 35):
- Mutations in this gene are linked to late-onset familial PD. VPS35 is involved in transporting proteins within cells and its malfunction can affect neuron survival.

2. Risk Genes for Sporadic Parkinson’s Disease:

While most Parkinson’s disease cases are not directly inherited, certain genes can increase the risk of developing PD in a more subtle way. These genetic variations, called risk genes, may not cause PD on their own but can increase susceptibility, especially when combined with environmental factors.

Notable Risk Genes:

GBA (Glucocerebrosidase):
- Mutations in the GBA gene, which is involved in lipid metabolism, are among the most common genetic risk factors for PD. People with GBA mutations are more likely to develop PD, although not all carriers will. GBA mutations are also associated with more severe disease progression and cognitive decline.
MAPT (Microtubule-associated protein tau):
- Variations in the MAPT gene, which is involved in the formation of tau protein, have been linked to an increased risk of both PD and other neurodegenerative diseases like Alzheimer’s.
LRRK2 (Leucine-rich repeat kinase 2):
- Besides its role in familial PD, common variations in LRRK2 can also increase the risk of sporadic PD.
HLA (Human leukocyte antigen):
- Variations in HLA genes, which are involved in immune system regulation, are linked to an increased risk of Parkinson’s, suggesting that inflammation and immune response may play a role in the disease.

3. Mitochondrial Dysfunction and Genetic Links:

Mitochondrial dysfunction is a key feature in PD pathology, and several genes linked to familial PD, such as PINK1 and Parkin, are involved in mitochondrial quality control.
Mitochondria, the energy-producing structures in cells, are crucial for neuron survival. Dysfunctional mitochondria lead to energy deficits in neurons, contributing to their degeneration in Parkinson’s disease.

4. Genetic Variability by Ethnicity:

LRRK2 mutations are more common in specific populations, such as Ashkenazi Jews and North African Berbers, suggesting that genetic risk factors for PD vary among ethnic groups.
Certain populations, like people of East Asian descent, may have unique genetic variations that contribute to differences in Parkinson’s disease risk and progression.

5. Gene-Environment Interactions:

Even in individuals with a genetic predisposition to PD, environmental factors such as pesticide exposure, head trauma, or rural living can trigger the onset of the disease.
For example, people with certain LRRK2 mutations may only develop PD if they are exposed to environmental toxins that interact with their genetic vulnerability.

6. Epigenetics:

Epigenetic factors, which refer to changes in gene expression without altering the DNA sequence, are also being studied for their role in Parkinson’s disease. These include influences from diet, lifestyle, and exposure to environmental toxins.
Epigenetic changes might help explain why some people with genetic mutations develop PD while others do not.

Conclusion:

Genetic factors play a crucial role in both familial and sporadic Parkinson’s disease, with several specific genes directly linked to the disease or increasing susceptibility. While not all PD cases are hereditary, understanding the genetic basis of the disease helps in identifying high-risk individuals, understanding disease mechanisms, and developing targeted therapies. Genetic counseling and testing may be helpful for families with a history of PD or individuals with early-onset disease.